CompoAtlas

THÉRALICA SOUPLESSE ARTICULAIRE

Food supplement declared in France, decision dated 14 February 2025

THÉRALICA SOUPLESSE ARTICULAIRE, from Theragreen, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: méthylsulfonate de méthane 600 mg per day, Harpagophytum zeyheri 50 mg per day, Harpagophytum procumbens 50 mg per day, Lactobacillus Plantarum Lactobacillus Plantarum 1.1 (unit not declared) per day, Lacticaseibacillus Rhamnosus Lactobacillus Rhamnosus 1.1 (unit not declared) per day. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
Theragreen
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Capsule
Daily dose
3 gélules
Directions for use
Prendre 2 gélules par jour de blister bleu et 1 gélule par jour de blister vert les 15 premiers jours, avec un verre d’eau.
Intended populations
Men and women aged 18 and over
Not recommended (according to the manufacturer)
Breastfeeding women, Children (under 12), Young children (aged 1 to 3), Pregnant women, Ulcer (stomach or duodenum), Children (under 6), Children (under 10)
Objectives stated by the manufacturer (these are not authorised claims)
Joints

Declaration 7762, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Harpagophytum zeyheri DecneRacineExtrait sec aqueux50 mg
Harpagophytum procumbensRacineExtrait sec aqueux50 mg

Substances

NamePer day
méthylsulfonate de méthane600 mg

Micro-organisms

StrainPer day
Lactobacillus Plantarum Lactobacillus Plantarum1.1 (unit not declared)
Lacticaseibacillus Rhamnosus Lactobacillus Rhamnosus1.1 (unit not declared)
Lactobacillus Casei Lactobacillus Casei1.1 (unit not declared)

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
selenium enriched yeastSelenium255 µg50 µg
zinc citrateZinc25 mg15 mg

Additives

E464, E470b

Other ingredients

maltodextrine

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Les compléments alimentaires doivent être utilisés dans le cadre d’un mode de vie sain et ne pas être utilisés comme substituts d’un régime alimentaire varié et équilibré. Ne pas dépasser la dose journalière recommandée. A conserver au sec et à l'abri de la lumière. Tenir hors de la portée des jeunes enfants. L'emploi est déconseillé en cas d'ulcères (estomac ou duodenum) ou de calculs biliaires. Déconseillé chez les femmes enceintes et allaitantes. Réservé à l’adulte.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Harpagophytum zeyheri Decne
    Read the warning, when it applies and the studies cited

    DEVIL'S CLAW - HARPAGOPHYTUM

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Health Canada monograph dated 27 March 2026

  • Harpagophytum procumbens
    Read the warning, when it applies and the studies cited

    DEVIL'S CLAW - HARPAGOPHYTUM

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Health Canada monograph dated 27 March 2026

  • méthylsulfonate de méthane
    Read the warning, when it applies and the studies cited

    MSM

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Known adverse reactions

    When using this product you may experience gastrointestinal discomfort/disturbances (Kim et al. 2005).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “THÉRALICA SOUPLESSE ARTICULAIRE: composition and regulation”, https://compoatlas.com/en/supplements/products/7762-theralica-souplesse-articulaire, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line